Cimerli (ophthalmic)

Cimerli (ophthalmic)

From 868.75$

Active Ingredients

ranibizumab

Drug Classes

Anti-angiogenic ophthalmic agents

Scoring is done by our AI based assistant on the data from the FDA and other sources

7.8

/

10

Effectiveness

Safety

Addiction

Ease of Use

Contraindications

Cimerli (ophthalmic): Alternative Drugs By Action

6.7

Avacincaptad pegol (Intraocular)

6.2

Opuviz

6.1

Lucentis

5.2

Pegaptanib (Intraocular)

5.2

Ranibizumab-eqrn (Intraocular)

5.2

Faricimab-svoa (Intraocular)

4.8

Ranibizumab (Intraocular)

4.6

Susvimo

1
2

Browse Drugs by Alphabet